MoonLake Immunotherapeutics Ratios (2020-2026) | MLTX

Ratios Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Efficiency
Assets Average (Quarter)
116.43M116.31M62.96M120.45M164.82M93.51M82.72M71.82M286.71M503.42M513.38M545.33M554.50M531.55M498.07M494.60M485.68M437.22M419.38M412.40M
Equity Average (Quarter)
0.29M-1.14M-7.37M-18.46M34.65M88.56M75.67M63.94M279.11M494.38M501.57M532.94M541.21M512.77M471.16M429.70M385.26M323.43M296.69M279.25M
Invested Capital (Quarter)
0.83M-3.10M3.35M-25.27M94.56M82.57M68.77M59.11M499.11M489.64M513.49M552.39M530.03M495.50M446.82M485.60M431.34M362.61M378.58M353.02M
Leverage & Solvency
Interest Coverage Ratio (Quarter)
-0.02M-0.00M-29.80-22.34-32.71-30.86
Debt to Equity (Quarter)
-1.29
Debt Ratio (Quarter)
1.55
Equity Ratio (Quarter)
0.01-0.03-1.20-0.110.960.930.890.880.990.980.980.980.970.960.930.810.780.700.720.63
Times Interest Earned (Quarter)
-0.02M-0.00M-29.80-22.34-32.71-30.86
Valuation
Enterprise Value (Quarter)
-1.10M-1.03M-8.04M-101.02M31.04M-56.22M-52.25M-45.92M-492.47M-431.27M-493.19M-537.22M-510.43M-486.62M-441.46M-475.07M-420.87M-378.19M-393.97M-357.92M
Return Ratios
Return on Capital Employed (Quarter)
-221.17%131.73%-58.05%-116.51%-86.69%-96.14%-20.60%-11.31%-10.75%-11.37%-14.46%-21.22%-30.09%-36.28%-43.83%-58.94%-65.48%-73.00%
Return on Invested Capital (Quarter)
0.10%-0.03%-0.01%-0.01%-0.01%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-0.01%-0.01%-0.01%
Return on Assets (Quarter)
0.00%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-0.01%-0.01%
Return on Equity (Quarter)
0.34%0.13%0.06%-0.03%-0.01%-0.01%-0.01%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-0.01%-0.01%-0.01%